Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: Possible involvement in the pathogenesis of human H5N1 virus infection

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 667-678

  Zeng, Hui ^a   Pappas, Claudia ^a   Belser, Jessica A ^a   Houser, Katherine V ^a   Zhong, Weiming ^a   Wadford, Debra A ^a,d   Stevens, Troy ^c   Balczon, Ron ^b,c   Katz, Jacqueline M ^a   Tumpey, Terrence M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^d VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INFLUENZA VIRUS HEMAGGLUTININ; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; AVIAN INFLUENZA VIRUS; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PRIORITY JOURNAL; RAT; VIRAL TROPISM; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CELL LINE; CHICK EMBRYO; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; LUNG; RATS; RESPIRATORY DISTRESS SYNDROME, ADULT; VIRULENCE; VIRUS REPLICATION;

AVES; AVIAN INFLUENZA VIRUS; MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 84856844125     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06348-11     Document Type: Article

References (57)

1. Abdel-Ghafar AN, et al. 2008. Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med. 358:261-273.
2. Alom-Ruiz SP, Anilkumar N, Shah AM. 2008. Reactive oxygen species and endothelial activation. Antioxid. Redox Signal. 10:1089-1100.
3. Azoulay E, et al. 2002. Deterioration of previous acute lung injury during neutropenia recovery. Crit. Care Med. 30:781-786.
4. Baskin CR, et al. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 106:3455-3460.
5. Belser JA, et al. 2008. Contemporary North American influenza H7 viruses possess human receptor specificity: implications for virus transmissibility. Proc. Natl. Acad. Sci. U. S. A. 105:7558-7563.
6. Belser JA, Wadford DA, Xu J, Katz JM, Tumpey TM. 2009. Ocular infection of mice with influenza A (H7) viruses: a site of primary replication and spread to the respiratory tract. J. Virol. 83:7075-7084.
7. Belser JA, Zeng H, Katz JM, Tumpey TM. 2011. Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection. J. Infect. Dis. 203: 40-48.
8. Bertram S, Glowacka I, Steffen I, Kuhl A, Pohlmann S. 2010. Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev. Med. Virol. 20:298-310.
9. Birkness KA, et al. 1999. An in vitro tissue culture bilayer model to examine early events in Mycobacterium tuberculosis infection. Infect. Immun. 67:653-658.
10. Bottcher-Friebertshauser E, et al. 2010. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J. Virol. 84: 5605-5614.
11. Chan MC, et al. 2009. Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Respir. Res. 10:102.
12. Chosewood LC, Wilson DE. 2009. Biosafety in microbiological and medical laboratories. U. S. Department of Health andHumanServices, Washington, DC. http://www.cdc.gov/biosafety/publications/bmbl5/BMBL.pdf.
13. Chutinimitkul S, et al. 2006. H5N1 influenza A virus and infected human plasma. Emerg. Infect. Dis. 12:1041-1043.
14. Cotran RS, Kumar V, Collins T (ed). 1999. Robbins pathologic basis of disease, 6th ed. W.B. Saunders Company, Philadelphia, PA.
15. Decha P, et al. 2008. Source of high pathogenicity of an avian influenza virus H5N1: why H5 is better cleaved by furin. Biophys. J. 95:128-134.
16. de Jong MD, et al. 2005. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med. 352:686-691.
17. de Jong MD, et al. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12: 1203-1207.
18. Deng R, et al. 2008. Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients. J. Pathol. 216:328-336.
19. Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y. 2008. Human infection with highly pathogenic H5N1 influenza virus. Lancet 371:1464-1475.
20. Gu J, et al. 2007. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370:1137-1145.
21. Guo XL, Li L, Wei DQ, Zhu YS, Chou KC. 2008. Cleavage mechanism of the H5N1 hemagglutinin by trypsin and furin. Amino Acids 35: 375-382.
22. Ibricevic A, et al. 2006. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 80:7469-7480.
23. King J, et al. 2004. Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc. Res. 67:139-151.
24. Klenk HD, Garten W. 1994. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2:39-43.
25. Korteweg C, Gu J. 2008. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol. 172: 1155-1170.
26. Kuiken T, van den Brand J, van Riel D, Pantin-Jackwood M, Swayne DE. 2010. Comparative pathology of select agent influenza a virus infections. Vet. Pathol. 47:893-914.
27. Kusters S, et al. 1997. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 27:2870-2875.
28. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. 2007. A question of self-preservation: immunopathology in influenza virus infection. Immunol. Cell Biol. 85:85-92.
29. Lamb RA, Krug RM (ed). 1996. Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, PA.
30. Lu X, et al. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73:5903-5911.
31. Maines TR, et al. 2005. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79:11788-11800.
32. Mehta PK, Karls RK, White EH, Ades EW, Quinn FD. 2006. Entry and intracellular replication of Mycobacterium tuberculosis in cultured human microvascular endothelial cells. Microb. Pathog. 41:119-124.
33. Nakayama K. 1997. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem. J. 327:625-635.
34. Ng WF, To KF, Lam WW, Ng TK, Lee KC. 2006. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1-a review. Hum. Pathol. 37:381-390.
35. Nicholls JM, et al. 2007. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 13:147-149.
36. Ocana-Macchi M, et al. 2009. Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells. J. Virol. 83: 12947-12955.
37. Park MS, Steel J, Garcia-Sastre A, Swayne D, Palese P. 2006. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. U. S. A. 103:8203-8208.
38. Peiris JS, et al. 2004. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363:617-619.
39. Perrone LA, Szretter KJ, Katz JM, Mizgerd JP, Tumpey TM. 2010. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J. Infect. Dis. 202:1161-1170.
40. Shinya K, et al. 2006. Avian flu: influenza virus receptors in the human airway. Nature 440:435-436.
41. Steinhauer DA. 1999. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1-20.
42. Suzuki Y, et al. 2000. Sialic acid species as a determinant of the host range of influenza A viruses. J. Virol. 74:11825-11831.
43. Thanh TT, van Doorn HR, de Jong MD. 2008. Human H5N1 influenza: current insight into pathogenesis. Int. J. Biochem. Cell Biol. 40: 2671-2674.
44. To KF, et al. 2001. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J. Med. Virol. 63:242-246.
45. Tran TH, et al. 2004. Avian influenza A (H5N1) in 10 patients in Vietnam. N. Engl. J. Med. 350:1179-1188.
46. Tumpey TM, et al. 2005. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310:77-80.
47. Uyeki TM. 2009. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin. Infect. Dis. 49:279-290.
48. Vandenbroucke E, Mehta D, Minshall R, Malik AB. 2008. Regulation of endothelial junctional permeability. Ann. N. Y. Acad. Sci. 1123:134-145.
49. van Riel D, et al. 2006. H5N1 virus attachment to lower respiratory tract. Science 312:399.
50. van Riel D, et al. 2007. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol. 171:1215-1223.
51. Walls HH, Harmon MW, Slagle JJ, Stocksdale C, Kendal AP. 1986. Characterization and evaluation of monoclonal antibodies developed for typing influenzaAand influenza B viruses. J. Clin. Microbiol. 23:240-245.
52. Ware LB. 2006. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 27:337-349.
53. Yao L, Korteweg C, Hsueh W, Gu J. 2008. Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J. 22:733-740.
54. Yu H, et al. 2008. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One 3:e2985.
55. Zeng H, et al. 2007. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J. Virol. 81:12439-12449.
56. Zeng H, Pappas C, Katz JM, Tumpey TM. 2011. The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells. J. Virol. 85:686-696.
57. Zhang Z, et al. 2009. Systemic infection of avian influenza A virus H5N1 subtype in humans. Hum. Pathol. 40:735-739.